United States Point-of-Care Diagnostics Market Size, Growth & Forecast | Major Players 2025 - BD, QuidelOrtho Corporation, QIAGEN

"Point of Care Diagnostics Market reached US$ 44.72 Billion in 2024 and is expected to reach US$ 106.35 Billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/point-of-care-diagnostics-market?sp

United States: Recent Industry Developments

✅ In September 2025, Abbott Laboratories launched a next-generation point-of-care diagnostic device for rapid detection of infectious diseases, integrating AI-based analysis for improved accuracy and faster results in clinical settings.

✅ In August 2025, Roche Diagnostics completed the acquisition of T2 Biosystems, enhancing its portfolio in rapid molecular diagnostics and expanding its point-of-care testing capabilities for hospitals and emergency care.

✅ In July 2025, Quidel Corporation invested $40 million to expand its production facility for rapid diagnostic test kits, supporting increased demand for point-of-care solutions in both clinical and community health settings.

✅ In June 2025, BD (Becton, Dickinson and Company) launched a new compact point-of-care analyzer for multiple biomarkers, enabling clinicians to conduct rapid, near-patient testing with integrated data reporting.

Japan: Recent Industry Developments

✅ In September 2025, Sysmex Corporation introduced a new point-of-care hematology analyzer for hospitals and clinics, combining speed, precision, and user-friendly design for improved patient care.

✅ In August 2025, Fujifilm Holdings launched a portable molecular diagnostic device for infectious disease testing, optimized for field use and telemedicine integration.

✅ In July 2025, Sekisui Medical Co., Ltd. invested in expanding its point-of-care diagnostics manufacturing capabilities, focusing on rapid immunoassay kits and compact testing devices for hospitals.

✅ In June 2025, Terumo Corporation introduced a new line of point-of-care blood gas and electrolyte analyzers, designed to deliver accurate results in critical care and emergency environments.

Point-of-Care Diagnostics Market: Drivers

The point-of-care (POC) diagnostics market is experiencing rapid growth due to rising demand for rapid, accurate, and decentralized testing solutions in hospitals, clinics, and home healthcare settings. POC diagnostics enable timely decision-making by providing immediate results for conditions such as infectious diseases, chronic illnesses, cardiac events, and metabolic disorders. Increasing awareness about early detection, preventive care, and personalized medicine is driving adoption among healthcare providers and patients. The expansion of healthcare infrastructure, growing prevalence of chronic and infectious diseases, and rising demand for outpatient and remote care solutions are further supporting market growth.

Technological advancements in microfluidics, biosensors, lateral flow assays, and portable diagnostic devices are enhancing the accuracy, convenience, and speed of POC testing. Integration with digital health platforms, mobile apps, and electronic health records (EHRs) is improving data management, remote monitoring, and clinical decision-making. Regulatory support and reimbursement frameworks for rapid diagnostic tests are encouraging wider adoption in emerging and developed markets. Growing emphasis on reducing healthcare costs and improving patient outcomes is further fueling demand for POC solutions. Collectively, these factors are driving sustained growth in the point-of-care diagnostics market as healthcare systems increasingly prioritize fast, reliable, and accessible testing technologies.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/point-of-care-diagnostics-market?sp

Point-of-Care Diagnostics Market: Major Players

BD, QuidelOrtho Corporation, QIAGEN, Trinity Biotech plc, BioMérieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, and SEKISUI MEDICAL CO., LTD., among others.

Segment Covered in the Point-of-Care Diagnostics Market:

➥ By Product: Infectious Disease Testing Products, Blood Glucose Products, Blood Gas & Electrolyte Products, Hematology Testing Products, Urinalysis Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Profiling Products, Drug-of-Abuse Products, Others
➥ By Technology: Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Microfluidics, Others
➥ By Application: Infectious Diseases, Hematology, Cardiology, Endocrinology, Oncology, Drug Testing, Neurology, Others
➥ By End-user: Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgery Centers (ASCs), Home Care Settings

Research Process:

Both primary and secondary data sources have been used in the Point-of-Care Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Point-of-Care Diagnostics Market Research Industry:

➠ Who leads the Point-of-Care Diagnostics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Point-of-Care Diagnostics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Point-of-Care Diagnostics market growth?
➠ What are the dominant sales and distribution strategies in the Point-of-Care Diagnostics industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=point-of-care-diagnostics-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.